Procter & Gamble (NYSE:PG) Trading Up 1.2% - Here's Why

Key Points

• Shares rose 1.2% to about $146.69 on Thursday while volume was roughly 40% below average; the stock sits in a large‑cap consumer staples profile (market cap ~ $341B, P/E ~21.7).
• Positive catalysts include a multi‑year WNBA partnership and renewed emphasis on its “lifeblood” innovation strategy, aimed at driving brand relevance with younger consumers and supporting medium‑term growth and margins.
• Near‑term headwinds — several major brokers trimmed price targets (e.g., UBS, RBC, Goldman, Wells Fargo) and company insiders sold sizable stakes, which reduces upside expectations and heightens execution sensitivity.

Procter & Gamble Company (The) (NYSE:PG - Get Free Report)'s stock price was up 1.2% during trading on Thursday . The company traded as high as $146.94 and last traded at $146.6870. Approximately 6,779,216 shares changed hands during trading, a decline of 40% from the average daily volume of 11,376,662 shares. The stock had previously closed at $144.90.

Procter & Gamble News Summary

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: P&G announced a multi‑year, multi‑brand partnership with the WNBA to boost brand relevance, athlete collaborations and digital storytelling — a move aimed at driving engagement with younger and growing audiences that can support long‑term top‑line growth. P&G WNBA Partnership Aims To Build Brand Relevance And Investor Interest
• Positive Sentiment: CNBC and other outlets highlighted P&G’s “lifeblood” innovation strategy as central to a turnaround — commentary that supports confidence in margin and growth initiatives over the medium term. The strategy P&G calls its 'lifeblood' and why it's key to the stock's turnaround
• Neutral Sentiment: P&G named a new health care CEO as a 33‑year veteran retires — a routine leadership succession in a strategic business unit; likely neutral for the broader stock absent guidance or structural change. P&G names new health care CEO as 33-year veteran retires
• Neutral Sentiment: Market write‑ups and analysis pieces explain recent swings and investor interest in PG as a widely watched consumer staple; these summaries help context but are unlikely to move the stock materially on their own. Why Procter & Gamble (PG) Outpaced the Stock Market Today
• Negative Sentiment: Several major brokers trimmed price targets over the past 48 hours — UBS cut its PT to $166 (keeps buy), RBC lowered to $167 (keeps outperform), Goldman Sachs lowered to $155 (neutral) and Piper Sandler cut to $142 (neutral). Those downgrades reduce near‑term upside expectations and increase sell‑side sensitivity to execution, pressuring the stock despite maintained ratings. RBC cuts PT to $167 UBS Lowers PT to $166
• Negative Sentiment: Wells Fargo also trimmed its target to $158 while keeping an overweight rating — another signal that analysts expect slower upside from current levels even if they remain constructive on the franchise. Wells Fargo trims PT to $158

Analyst Ratings Changes

A number of equities research analysts recently commented on PG shares. Dbs Bank upgraded shares of Procter & Gamble from a "hold" rating to a "buy" rating in a report on Friday, January 23rd. Weiss Ratings restated a "hold (c)" rating on shares of Procter & Gamble in a report on Friday, March 27th. Wells Fargo & Company dropped their price objective on shares of Procter & Gamble from $177.00 to $158.00 and set an "overweight" rating on the stock in a report on Wednesday. The Goldman Sachs Group dropped their price objective on shares of Procter & Gamble from $159.00 to $155.00 and set a "neutral" rating on the stock in a report on Wednesday. Finally, Jefferies Financial Group upgraded shares of Procter & Gamble from a "hold" rating to a "buy" rating and raised their price objective for the stock from $156.00 to $179.00 in a report on Tuesday, December 16th. Twelve investment analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $164.26.

Procter & Gamble Trading Up 1.2%

The firm has a market cap of $340.90 billion, a P/E ratio of 21.73, a P/E/G ratio of 5.04 and a beta of 0.41. The business's 50-day moving average is $153.23 and its two-hundred day moving average is $149.32. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.72 and a quick ratio of 0.51.

Procter & Gamble (NYSE:PG - Get Free Report) last released its earnings results on Friday, January 23rd. The company reported $1.88 earnings per share for the quarter, beating analysts' consensus estimates of $1.86 by $0.02. The business had revenue of $22.21 billion during the quarter, compared to the consensus estimate of $22.36 billion. Procter & Gamble had a net margin of 19.30% and a return on equity of 32.21%. The firm's revenue for the quarter was up 1.5% compared to the same quarter last year. During the same quarter last year, the firm earned $1.88 earnings per share. As a group, analysts predict that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.

Procter & Gamble Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, February 17th. Investors of record on Friday, January 23rd were given a $1.0568 dividend. The ex-dividend date of this dividend was Friday, January 23rd. This represents a $4.23 dividend on an annualized basis and a yield of 2.9%. Procter & Gamble's dividend payout ratio (DPR) is 62.67%.

Insiders Place Their Bets

In related news, insider Balaji Purushothaman sold 12,827 shares of the firm's stock in a transaction on Wednesday, February 11th. The shares were sold at an average price of $160.31, for a total value of $2,056,296.37. Following the completion of the transaction, the insider owned 12,639 shares of the company's stock, valued at approximately $2,026,158.09. This trade represents a 50.37% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Chairman Jon R. Moeller sold 162,232 shares of the firm's stock in a transaction on Thursday, February 12th. The shares were sold at an average price of $162.45, for a total transaction of $26,354,588.40. Following the completion of the transaction, the chairman directly owned 319,385 shares of the company's stock, valued at approximately $51,884,093.25. This trade represents a 33.68% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 348,618 shares of company stock valued at $55,462,643 in the last quarter. Company insiders own 0.20% of the company's stock.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the company. Halbert Hargrove Global Advisors LLC bought a new position in shares of Procter & Gamble in the 3rd quarter valued at about $25,000. E Fund Management Hong Kong Co. Ltd. grew its position in shares of Procter & Gamble by 1,000.0% in the 4th quarter. E Fund Management Hong Kong Co. Ltd. now owns 165 shares of the company's stock valued at $25,000 after acquiring an additional 150 shares during the period. Litman Gregory Wealth Management LLC bought a new position in shares of Procter & Gamble in the 4th quarter valued at about $26,000. Park Square Financial Group LLC grew its position in shares of Procter & Gamble by 65.1% in the 4th quarter. Park Square Financial Group LLC now owns 180 shares of the company's stock valued at $26,000 after acquiring an additional 71 shares during the period. Finally, Evolution Wealth Management Inc. grew its position in shares of Procter & Gamble by 1,315.4% in the 4th quarter. Evolution Wealth Management Inc. now owns 184 shares of the company's stock valued at $26,000 after acquiring an additional 171 shares during the period. Institutional investors own 65.77% of the company's stock.

About Procter & Gamble

Procter & Gamble NYSE: PG is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world's largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G's product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.